Loading...

Advicenne S.A.

ALDVI.PAEURONEXT
Healthcare
Biotechnology
1.76
0.01(0.57%)

Advicenne S.A. (ALDVI.PA) Company Profile & Overview

Explore Advicenne S.A.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Advicenne S.A. (ALDVI.PA) Company Profile & Overview

Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.

SectorHealthcare
IndustryBiotechnology
CEOMr. Didier Laurens

Contact Information

33 1 85 73 36 20
3ème étage 262, Paris, 75008

Company Facts

21 Employees
IPO DateDec 6, 2017
CountryFR
Actively Trading

Frequently Asked Questions

;